CLPTM1L and endometrial cancer: First, a ‘global’ test using the admixture maximum likelihood method (AML) (Tyrer et al. 2006) against the null hypothesis that none of the genotyped SNPs within the TERT–CLPTM1L region are associated with endometrial cancer provided significant evidence that at least one SNP is associated (P = 0.0001).